Characterization of the Prosocial and Prosexual Effects of GHB

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

December 31, 2014

Conditions
Depressive Disorder, MajorBipolar DisorderAutistic Disorder
Interventions
DRUG

GHB 35 mg/kg p.o.

GHB 35 mg/kg p.o.

DRUG

GHB 20 mg/kg p.o.

GHB 20 mg/kg p.o.

Trial Locations (1)

8032

Hospital for Psychiatry, University of Zurich, Zurich

All Listed Sponsors
collaborator

University of Regensburg

OTHER

collaborator

University of Salerno

OTHER

collaborator

University of Vienna

OTHER

collaborator

University of Freiburg

OTHER

lead

University of Zurich

OTHER

NCT02342366 - Characterization of the Prosocial and Prosexual Effects of GHB | Biotech Hunter | Biotech Hunter